New York, Global Pharmacovigilance (PV) Market report from Global Insight Services is the single authoritative source of intelligence on Pharmacovigilance (PV) Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Pharmacovigilance is the science and activities related to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.
Passive surveillance is the most common type of pharmacovigilance activity. It is important because it can identify previously unknown adverse events. However, it has some limitations, such as under-reporting and reporting bias.
Request sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS22087/
Key Trends
There are several key trends in PV technology:
1. The use of big data and machine learning to identify potential safety risks.
2. The use of predictive analytics to identify at-risk patients.
3. The use of social media monitoring to identify potential safety concerns.
4. The use of mobile technology to collect patient-reported data.
Key Drivers
The key drivers of pharmacovigilance (PV) market are the increasing number of clinical trials, the growing prevalence of chronic and life-threatening diseases, and the need for better patient safety.
The number of clinical trials has been increasing over the years as the pharmaceutical industry seeks to develop new and better treatments for various diseases. This has led to an increase in the number of patients being exposed to new drugs, which has in turn led to an increase in the need for PV.
The prevalence of chronic and life-threatening diseases is also a key driver of the PV market. As the population ages, the number of people suffering from chronic diseases such as cancer and heart disease is increasing. This is leading to a greater need for PV, as these patients are often taking multiple medications that need to be closely monitored for safety.
Finally, the need for better patient safety is also driving the PV market. In recent years, there have been a number of high-profile cases of patients being harmed by drugs that were not properly monitored. This has led to calls for better PV, which is helping to drive the market.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS22087/
Key Market Segments
The pharmacovigilance (PV) bifurcated on the basis of type, service provider, end-user, and region. On the basis of type, it is segmented into adverse drug reaction capture (ADR), case processing, reporting & submission, and others. By service provider, it is divided into up to contract research organization and business processing outsourcing. By end-user, it is analyzed across pharmaceutical industry, research organization, and others. Region-wise, it is studied across North America, Europe, Asia-Pacific, and rest of the World.
Key Market Players
The pharmacovigilance (PV) market report includes players such as Accenture, Linical Accelovance, Cognizant, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, and IQVIA.
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS22087/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700